dc.contributorNoriega-Ortega, B.R., Facultad de Medicina, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, Mexico; Armienta-Aldana, E., Facultad de Medicina, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, Mexico; Cervantes-Pompa, J. Á., Facultad de Medicina, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, Mexico; Armienta-Aldana, E., Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa (UAS), Culiacán, Sinaloa, Mexico; Hernández-Ruíz, E., Departamento de Farmacología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (U de G), Guadalajara, Jalisco, Mexico; Chaparro-Huerta, V., Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigacion Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico; Bravo-Cuellar, A., Laboratorio de Inmunología de los Tumores, División de Inmunología, Centro de Investigacion Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico; Beas-Zárate, C., Laboratorio de Neurobiología Celular y Molecular, División de Neurociencias, Centro de Investigacion Biomedica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico, Departamento de Biología Celular y Molecular, Centro Universitario de Ciencias Biológicas y Agropecuarias (CUCBA), Universidad de Guadalajara (U de G), Guadalajara, Jalisco, Mexico
dc.contributorBeas-Zárate, Carlos., Universidad de Guadalajara. Centro Universitario de Ciencias Biológicas y Agropecuarias
dc.creatorNoriega-Ortega, B.R.
dc.creatorArmienta-Aldana, E.
dc.creatorCervantes-Pompa, J., A.
dc.creatorArmienta-Aldana, E.
dc.creatorHernandez-Ruiz, E.
dc.creatorChaparro-Huerta, V.
dc.creatorBravo-Cuellar, A.
dc.creatorBeas-Zárate, Carlos
dc.date.accessioned2015-11-19T18:49:58Z
dc.date.accessioned2023-07-04T04:46:26Z
dc.date.available2015-11-19T18:49:58Z
dc.date.available2023-07-04T04:46:26Z
dc.date.created2015-11-19T18:49:58Z
dc.date.issued2011
dc.identifierhttp://hdl.handle.net/20.500.12104/65011
dc.identifier10.1293/tox.24.163
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-83255192484&partnerID=40&md5=6689b5d12199e3eff7f511850f8da47e
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7271036
dc.description.abstractOrganophosphates such as methamidophos, usually used in the agricultural field, have harmful effects on humans. Exposures to insecticides has been associated with many disorders, including damage to the central and peripheral nervous system. Chronic exposure to organophosphates may lead to persistent neurological and neurobehavioral effects. This study was conducted to determine the effect of methamidophos on [3H]-dopamine (DA) and gamma aminobutyric acid (GABA) release from different brain regions after chronic exposure to it for 3, 6 or 9 months. After a six-month methamidophos treatment, the mice showed high susceptibility to convulsive seizures and a reduction in stimulated gamma aminobutyric acid release from the cerebral cortex and hippocampal slices, whereas stimulated (DA) release was slightly decreased from the striatum after three months of methamidophos exposure. The results indicate changes in gamma aminobutyric acid and dopamine neurotransmission, suggesting a specific neuronal damage. © 2011 The Japanese Society of Toxicologic Pathology.
dc.relationJournal of Toxicologic Pathology
dc.relation24
dc.relation3
dc.relation163
dc.relation168
dc.relationScopus
dc.relationWOS
dc.titleGaba and dopamine release from different brain regions in mice with chronic exposure to organophosphate methamidophos
dc.typeArticle


Este ítem pertenece a la siguiente institución